Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 15, Number 9—September 2009
Research

Chicken Consumption and Use of Acid-Suppressing Medications as Risk Factors for Campylobacter Enteritis, England

Clarence C. TamComments to Author , Craig D. Higgins, Keith R. Neal, Laura C. Rodrigues, Sally E. Millership, Sarah J. O’Brien, on behalf of the Campylobacter Case–Control Study Group
Author affiliations: London School of Hygiene and Tropical Medicine, London, UK (C.C. Tam, C.D. Higgins, L.C. Rodrigues); University of Nottingham, Nottingham, UK (K.R. Neal); Essex Health Protection Unit, Witham, UK (S.E. Millership); University of Manchester, Manchester, UK (S.J. O’Brien)

Main Article

Figure

Odds ratios (ORs) and 95% confidence intervals (shown in parentheses) for Campylobacter enteritis associated with chicken consumption, England, 2005–2006. Numbers in boxes represent persons in each category; Numbers in red indicate relevant comparisons; arrows indicate direction of risk. For boxes in the bottom level, ORs compare risk for Campylobacter enteritis between individuals in that group and the baseline group (labeled), which comprises persons who do not regularly eat chicken and did no

Figure. Odds ratios (ORs) and 95% confidence intervals (shown in parentheses) for Campylobacter enteritis associated with chicken consumption, England, 2005–2006. Numbers in boxes represent persons in each category; Numbers in red indicate relevant comparisons; arrows indicate direction of risk. For boxes in the bottom level, ORs compare risk for Campylobacter enteritis between individuals in that group and the baseline group (labeled), which comprises persons who do not regularly eat chicken and did not eat chicken in the previous 5 days (n = 334). Model is adjusted for age group, sex, study site, and month. *p<0.05; †p<0.01; ‡p<0.001.

Main Article

1The Campylobacter Case–Control Study Group comprises the following: Sarah J. O’Brien (Manchester University); Clarence C. Tam, Craig D. Higgins, Laura C. Rodrigues, and Brendan W. Wren (London School of Hygiene and Tropical Medicine); Keith R. Neal (University of Nottingham); Bob Owen and Judith Richardson (Health Protection Agency Centre for Infections); Bharat C. Patel (Health Protection Agency Collaborating Centre, North Middlesex Hospital); Peter Sheridan (North East and Central London HPU); John Curnow (Cheshire and Merseyside HPU); Ken Lamden (Cumbria and Lancashire HPU); and Sally Millership (Essex HPU).

Page created: December 07, 2010
Page updated: December 07, 2010
Page reviewed: December 07, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external